Neuroprotective Treatment in Primary Progressive Multiple Sclerosis: a Phase I/II Study with Riluzole

Early Indicators Early Treatments Neuroprotection in Multiple Sclerosis ◽

10.1007/978-88-470-2117-4_4 ◽

2004 ◽

pp. 41-47

Author(s):

N. Kalkers ◽

F. Barkhof ◽

L. Bergers ◽

R. Van Schijndel ◽

C. Polman

Keyword(s):

Multiple Sclerosis ◽

Phase I ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Primary Progressive ◽

Neuroprotective Treatment

Download Full-text

Searching for early CSF biomarkers of primary progressive multiple sclerosis

10.26226/morressier.5b719e465aff74008ae4cb58 ◽

2018 ◽

Author(s):

Damiano Marastoni ◽

Roberta Magliozzi

Keyword(s):

Multiple Sclerosis ◽

Progressive Multiple Sclerosis ◽

Csf Biomarkers ◽

Primary Progressive Multiple Sclerosis ◽

Primary Progressive

Download Full-text

A Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis

Case Medical Research ◽

10.31525/ct1-nct04035005 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Sclerosis ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Efficacy And Safety ◽

Primary Progressive

Download Full-text

Faculty Opinions recommendation of Meningeal inflammation plays a role in the pathology of primary progressive multiple sclerosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955622.793460622 ◽

2012 ◽

Author(s):

Monica Marta

Keyword(s):

Multiple Sclerosis ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Primary Progressive ◽

Meningeal Inflammation

Download Full-text

Faculty Opinions recommendation of Electrophysiological markers and predictors of the disease course in primary progressive multiple sclerosis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718018944.793478763 ◽

2013 ◽

Author(s):

Marco Rovaris

Keyword(s):

Multiple Sclerosis ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Disease Course ◽

Primary Progressive

Download Full-text

Gray Matter Atrophy in the Cortico-Striatal-Thalamic Network and Sensorimotor Network in Relapsing–Remitting and Primary Progressive Multiple Sclerosis

Neuropsychology Review ◽

10.1007/s11065-021-09479-3 ◽

2021 ◽

Author(s):

Yuan Cao ◽

Wei Diao ◽

Fangfang Tian ◽

Feifei Zhang ◽

Laichang He ◽

...

Keyword(s):

Multiple Sclerosis ◽

Gray Matter ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Sensorimotor Network ◽

Primary Progressive ◽

Gray Matter Atrophy ◽

Relapsing Remitting

Download Full-text

Societal costs of primary progressive multiple sclerosis in Australia and the economic impact of a hypothetical disease-modifying treatment that could delay disease progression

Journal of Medical Economics ◽

10.1080/13696998.2021.1872585 ◽

2021 ◽

Vol 24 (1) ◽

pp. 140-149

Author(s):

Laurie J. Brown ◽

Jinjing Li ◽

Matthias Brunner ◽

Martin Snoke ◽

Hai A. La

Keyword(s):

Multiple Sclerosis ◽

Economic Impact ◽

Disease Progression ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Societal Costs ◽

Primary Progressive ◽

Delay Disease Progression ◽

Disease Modifying ◽

Disease Modifying Treatment

Download Full-text

Short-term data on disease activity, cognition, mood, stigma and employment outcomes in a cohort of patients with primary progressive multiple sclerosis (UPPMS study)

Multiple Sclerosis and Related Disorders ◽

10.1016/j.msard.2021.102860 ◽

2021 ◽

Vol 50 ◽

pp. 102860 ◽

Author(s):

Francisco Pérez-Miralles ◽

Daniel Prefasi ◽

Antonio García-Merino ◽

José Ramón Ara ◽

Guillermo Izquierdo ◽

...

Keyword(s):

Multiple Sclerosis ◽

Disease Activity ◽

Employment Outcomes ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Primary Progressive ◽

Download Full-text

Treatment for patients with primary progressive multiple sclerosis

Multiple Sclerosis Therapeutics ◽

10.1017/cbo9781139023986.055 ◽

2011 ◽

pp. 604-613

Author(s):

Zhaleh Khaleeli ◽

Alan J. Thompson

Keyword(s):

Multiple Sclerosis ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Primary Progressive

Download Full-text

Efficient Generation of Myelinating Oligodendrocytes from Primary Progressive Multiple Sclerosis Patients by Induced Pluripotent Stem Cells

Stem Cell Reports ◽

10.1016/j.stemcr.2014.06.012 ◽

2014 ◽

Vol 3 (2) ◽

pp. 250-259 ◽

Author(s):

Panagiotis Douvaras ◽

Jing Wang ◽

Matthew Zimmer ◽

Stephanie Hanchuk ◽

Melanie A. O’Bara ◽

...

Keyword(s):

Multiple Sclerosis ◽

Induced Pluripotent Stem Cells ◽

Pluripotent Stem Cells ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Primary Progressive ◽

Efficient Generation ◽

Induced Pluripotent ◽

Multiple Sclerosis Patients

Download Full-text

Aberrant expression of β-catenin in CD4+ T cells isolated from primary progressive multiple sclerosis patients

Neuroscience Letters ◽

10.1016/j.neulet.2017.05.057 ◽

2017 ◽

Vol 653 ◽

pp. 159-162 ◽

Author(s):

Sabrina Giacoppo ◽

Oxana Bereshchenko ◽

Stefano Bruscoli ◽

Carlo Riccardi ◽

Placido Bramanti ◽

...

Keyword(s):

Multiple Sclerosis ◽

T Cells ◽

Cd4 T Cells ◽

Progressive Multiple Sclerosis ◽

Primary Progressive Multiple Sclerosis ◽

Aberrant Expression ◽

Primary Progressive ◽

Multiple Sclerosis Patients

Download Full-text